Management ChangeApr 30, 2026, 08:50 AM
RCEL Appoints Cary Vance as CEO; Jan Stern Reed as Board Chair
AI Summary
AVITA Medical, Inc. announced the appointment of Cary Vance as President and Chief Executive Officer, effective immediately. Mr. Vance had been serving as Interim CEO since October 2025 and will continue to serve on the Board. The Board also appointed Jan Stern Reed as its Chair, effective immediately. Ms. Reed has served on the Board since 2021 and was previously the Lead Independent Director since October 2025. The company also confirmed its first quarter 2026 earnings call for May 14, 2026.
Key Highlights
- Cary Vance appointed President and Chief Executive Officer, effective immediately.
- Jan Stern Reed elected as Chair of the AVITA Medical Board, effective immediately.
- Mr. Vance served as Interim CEO since October 2025.
- Ms. Reed has served on the Board since 2021 and as Lead Independent Director since October 2025.
- Company will host its first quarter 2026 earnings call on Thursday, May 14, 2026.